Target intelligence / Profile preview

Hemozoin (HZ) (HZ)

Target
HZ
Molecular classification
Other
01

Overview

Hemozoin is an insoluble biocrystal produced by Plasmodium falciparum and other blood-feeding parasites to detoxify free heme released during the digestion of host hemoglobin (Sullivan, 2002, International Journal for Parasitology). Within the acidic digestive vacuole of the parasite, hemoglobin is proteolytically degraded to provide amino acids, a process that liberates ferriprotoporphyrin IX (heme). Free heme is highly toxic to the parasite as it generates reactive oxygen species and destabilizes cellular membranes (Egan, 2008, Journal of Inorganic Biochemistry). To mitigate this toxicity, the parasite sequesters heme into chemically inert hemozoin crystals. This crystallization process is the primary target for several classes of antimalarial drugs, particularly the 4-aminoquinolines like chloroquine. These drugs bind to the surface of the growing hemozoin crystals or to free heme, preventing further incorporation of heme into the crystal lattice (Weissbuch & Leiserowitz, 2008, Chemical Reviews). The resulting buildup of toxic free heme leads to the lysis of the digestive vacuole and the eventual death of the parasite.

Other names
Malaria pigmentBeta-hematinHeme biocrystal
02

Mechanism of action

Inhibition of heme biocrystallization into hemozoin, resulting in the accumulation of free ferriprotoporphyrin IX (heme), which is toxic to the parasite by causing membrane damage and oxidative stress.

03

Biological functions

Other
04

Disease associations

Infection
05

Safety considerations

Drug resistance mediated by PfCRT mutationsRetinal toxicity (with long-term quinoline use)Cardiotoxicity (QT prolongation)
06

Interacting drugs

Chloroquine

6 more in the full profile.

07

Biomarkers

Hemozoin pigmentHistidine-rich protein 2 (HRP2)Parasite-derived lactate dehydrogenase (pLDH)

Beyond the preview

Go deeper on Hemozoin (HZ) (HZ).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Hemozoin (HZ) (HZ).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call